Correcting the drug development paradigm for glioblastoma requires serial tissue sampling is a research paper published in Nature Medicine (2023). On theSindex it has a DataRank of 0.604. It has been cited 55 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.604
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Cancer Research UK
Grant: 17870
Medical Research Council
Grant: G0802755
Medical Research Council
Grant: G108/589
Cancer Research UK
Grant: 28832
Cancer Research UK
Grant: 11423
NCI NIH HHS
Grant: T32 CA009111
NCI NIH HHS
Grant: P50 CA211015
Cancer Research UK
Grant: 28803
Cancer Research UK
Grant: 20546
Cancer Research UK
Grant: 20747
FWCI
9.15
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords